Pedigree chart drawing tool with customizable family-health-history questionnaires for clinicians.
Explore competitors
FamGenix: A risk assessment platform linking patients and providers for hereditary disease analysis.
FamGenix is dedicated to enhancing precision medicine by providing a platform that connects patients and healthcare providers for hereditary disease risk assessment. Their core mission is to deliver accurate screening, identification, and assessment solutions for all types of hereditary diseases. FamGenix offers comprehensive pedigree risk assessments with embedded cancer risk models and population screening solutions, catering to healthcare companies worldwide.
FamGenix has achieved significant recognition and trust from leading healthcare organizations globally. Their impact is marked by the integration of family health history tools that improve the accuracy and completeness of hereditary disease analysis. By focusing on precision medicine, FamGenix contributes to better patient outcomes and more effective disease management strategies.

Nest Genomics
nestgenomics.com

Progeny Genetics

PhenoTips
phenotips.com

Nucleus
mynucleus.com

InformedDNA
informeddna.com

TapGenes

CancerIQ
canceriq.com

Visible Genomics
visiblegenomics.io

Probably Genetic

PreciseDx
precisedx.ai

Allelica
allelica.com

Haplotype Labs
haplotypelabs.com

ThinkGenetic
thinkgenetic.com
Sama Fertility

Fabric Genomics
fabricgenomics.com

Color
color.com

My Gene Counsel
mygenecounsel.com

Orchid
orchidhealth.com

Geneial
geneial.com

Geneoscopy
geneoscopy.com
Companies similar to FamGenix include Nest Genomics, Progeny Genetics, PhenoTips and Nucleus.
FamGenix was founded in 2018.
FamGenix's headquarters is located in Boynton Beach, FL, US.
FamGenix's most recent funding round was for $300k (USD) in June 2023.
As of Jun 29, 2023, FamGenix has disclosed funding of $787k (USD).
FamGenix has 16 employees as of Feb 4, 2024.